Thursday, May 23, 2019 2:35:02 PM
Start the leg up to TMX $2 or Nasdaq $4...
Rats were .78c(dec 2014) June 30 2014 and the shares were 79m so 61m cap.
Are we really saying that on a market cap basis 145m that we're a 65m cap with Phase 1 Exploratory Efficacy? (barely over Rats??)
Might be the most undervalued biotech of all time once 90 days hits..
Very tired of being in the pennies... Humans = Dolla Dollas.
Rats were .78c(dec 2014) June 30 2014 and the shares were 79m so 61m cap.
Are we really saying that on a market cap basis 145m that we're a 65m cap with Phase 1 Exploratory Efficacy? (barely over Rats??)
Might be the most undervalued biotech of all time once 90 days hits..
Very tired of being in the pennies... Humans = Dolla Dollas.
Recent TLTFF News
- Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update • Newsfile • 05/04/2026 09:22:00 PM
- Theralase(R) Closes $CAN 2.66 Million Financing • Newsfile • 04/10/2026 11:00:00 AM
- Theralase(R) Closes $1.1 M Non-Brokered Private Placement • Newsfile • 03/10/2026 11:00:00 AM
- Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer • Newsfile • 03/09/2026 11:00:00 AM
- Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/20/2026 12:00:00 PM
- Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/17/2026 12:00:00 PM
- Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting • Newsfile • 02/10/2026 12:00:00 PM
- Theralase(R) Provides Update on Bladder Cancer Clinical Study • Newsfile • 02/04/2026 12:00:00 PM
- Theralase and Ferring ink deal for new bladder cancer study • IH Market News • 01/14/2026 11:05:00 AM
- New Bladder Cancer Collaboration Sparks Sharp Rally in This Micro Cap Stock • AllPennyStocks.com • 01/12/2026 03:23:00 PM
- Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer • Newsfile • 01/12/2026 12:00:00 PM
- Theralase(R) Closes $1.3 M Non-Brokered Private Placement • Newsfile • 12/23/2025 09:40:00 PM
- Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing • Newsfile • 12/12/2025 10:00:00 PM
- Theralase(R) Investor Conference Call Reminder • Newsfile • 11/17/2025 12:00:00 PM
- Theralase(R) Releases 3Q2025 Financial Statements • Newsfile • 11/10/2025 12:00:00 PM
- Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus • Newsfile • 09/24/2025 11:00:00 AM

